Actinomycin D (Dactinomycin) Mechanism of Action: RNA Polymerase Inhibition in Cancer Cell Research

Actinomycin D (Dactinomycin) MOA:Targeting RNA Polymerase/DNA Damage Response Pathway for Pediatric Oncology and Rare Cancers

🎯 check Actinomycin D (Dactinomycin) product page

Actinomycin D is a potent DNA-intercalating RNA polymerase inhibitor. It affects p53, MAPK, and NF-κB signaling pathways by blocking DNA-dependent RNA synthesis, thereby inhibiting cell proliferation and promoting apoptosis.

Primary Applications and Mechanism of Action